2024 Gastro Health Conference CSID Leadership Summit
- A CME Proceedings Newsletter
To claim 1.0 credit for this activity, please visit:
Release date: July 11, 2025
Expiration date: July 11, 2026

Target Audience
The joint providership estimates the initiative will attract an audience of 5,000 participants, including physicians, nurse practitioners, nurses, and physician assistants. A comprehensive reach optimization effort will be driven by the Gi Health Foundation (GiHF) and Gastroenterology & Hepatology Advanced Practice Providers (GHAPP) proprietary databases and educational portals. Outreach will focus on health care professionals who have opted-in for educational updates from GiHF and GHAPP.
Program Overview
The joint providership of Medical Education Resources (MER) and GiHF proposes to develop an accredited proceedings e-Newsletter on the management of patients with CSID. In addition to the content discussed during the CSID leadership summits and virtual mentorship sessions, additional expert opinions, recent publications, abstracts, and presentations from congress meetings will be reviewed as part of the e-Newsletter development process. The e-Newsletter will launch in February 2024 and reach more than 5,000 participants via GiHF’s and GHAPP’s educational portals and will be posted for a period of at least 12 months.
Educational Objectives
Upon completion of this activity, participants should be able to:
-
Describe the prevalence of CSID in patients with common GI disorders
-
Incorporate current diagnostic strategies to differentiate CSID from other causes of persistent diarrhea seen in clinical practice, particularly among patients with suspected IBS
-
Summarize benefits and limitations of current treatment
Faculty and Planners
Brooks Cash, MD
Kaitlin Colella, NP
Patrick Horne, NP
Julie Messick, PharmD
Daksesh Patel, DO
Kate Scarlata, MPH, RDN
Accreditation

In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and GI Health Foundation (GIHF). MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit
Medical Education Resources estimates each educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™️.
Disclosure of All Financial Relationships
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies all financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.
MER and GIHF planners have no relevant financial relationships to disclose.
Disclosures
Patrick Horne, NP
-
Consultant
-
AbbVie, Boehringer Ingelheim, GlaxoSmithKline, Intercept, Ipsen, Madrigal, Novo-Nordisk, Salix
-
Daksesh Patel, DO
-
Speaker
-
QOL Medical
-
Brooks Cash, MD
-
Speaker
-
Salix, AbbVie, QOL Medical, Ardelyx, Alnylam, Phathom, AstraZeneca, Napo, Regeneron
-
-
Consultant
-
AbbVie, Ardelyx, Phathom, AstraZeneca
-
-
Research grant
-
Napo
-
Kaitlin Colella, NP
-
Nothing to disclose.
Kate Scarlata, MPH, RDN
-
Consultant
-
Schar, Olipop, Ardelyx
-
-
Sponsor of podcast
-
Schar, QOL Medical, Activa, Salix Pharmaceuticals
-
-
Stock options
-
Fody foods
-
-
Sponsorship event
-
QOL Medical, Biomerica, Activa, BioK
-
-
Sponsorship
-
Ardelyx
-
Julie Messick, PharmD
-
Nothing to disclose.
Disclaimer
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, the Gi Health Foundation, and/or QOL Medical LLC. The authors have disclosed if there is any discussion of published and/ or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
Method of Participation
There are no fees for participating in and receiving credit for this activity. During the period July 11, 2025 - July 11, 2026 participants must 1) read the learning objectives and faculty disclosures, 2) study the educational activity, 3) complete the posttest by recording the best answer to each question, and 4) complete the evaluation form. A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 75% or better.
Please visit https://education.gihealthfoundation.org/content/gastro-health-csid-leadership-summit-cme-proceedings-newsletter-advanced-practice-providers to complete the post-test and evaluation.
Media
Internet
MER Privacy Policy
Fee Information
There is no fee for this educational activity.
This activity is jointly provided by Medical Education Resources and the Gi Health Foundation.
Supported by an educational grant from QOL Medical LLC.

